FDA Releases Guidance On Biosimilar Approvals At Last
The U.S. Food and Drug Administration on Thursday released much-awaited guidance for the biotech industry on how the agency will review biosimilars, the generic versions of biological drugs such as vaccines,...To view the full article, register now.
Already a subscriber? Click here to view full article